Allstate Corporation’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-32,842
Closed -$1.1M – 1500
2026
Q2
$1.1M Buy
32,842
+1,464
+5% +$36.4K 0.01% 714
2026
Q1
$657K Buy
+31,378
New +$707K 0.01% 937

Other funds holding RARE

Allstate Corporation's RARE Position: Q3 2026 in Review

Allstate Corporation sold out of Ultragenyx Pharmaceutical (RARE) in Q3 2026, closing a stake of 32,842 shares — an estimated $1.1M sold.

Allstate Corporation first reported a position in RARE in Q1 2026 and held it in 2 quarters. The position peaked at $1.1M in Q2 2026. 263 funds tracked by Wall St. Rank hold RARE as of Q3 2026.

  • Allstate Corporation reported no remaining Ultragenyx Pharmaceutical position as of Q3 2026 after selling out during the quarter.
  • Allstate Corporation sold 32,842 Ultragenyx Pharmaceutical shares in Q3 2026, an estimated $1.1M.
  • Allstate Corporation first reported a position in Ultragenyx Pharmaceutical in Q1 2026 and held it in 2 quarters.
  • Allstate Corporation's Ultragenyx Pharmaceutical position peaked at $1.1M in Q2 2026.
  • 263 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.

Based on Allstate Corporation's 13F filing for Q3 2026, filed 16 Nov 2026.